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Background: The pathological damage inflicted by virulent AIV strains is often caused by inducing a positive
feedback loop of cytokines in immune cells that cause excessive inflammation. Previous research has shown that a
G protein-coupled receptor, sphingosine-1-phosphate receptor 1 (S1PR1), plays a crucial role in the development of
excessive inflammation in influenza virus infection (Cell 146:861–862, 2011; Cell 146:980–991, 2011). BALB/c mice are
common laboratory animals used in research of influenza virus; however the effects of influenza infections on
expression patterns of S1PR1 in mice are unknown.
Methods: We investigated the expression patterns of S1PR1 in normal BALB/c mice and those infected by two
distinct H9N2 AIV strains, one (A/chicken/Guangdong/V/2008,V) highly pathogenic, and the other (A/chicken/
Guangdong/Ts/2004,Ts), non-pathogenic in mice, using quantitative PCR and immunohistochemistry (IHC) to detect
S1PR1 mRNA and protein, respectively.
Results: S1PR1 mRNA was ubiquitously expressed in all the tissues examined, and significant differences were seen
in mRNA expression between infected Ts, V and control mice in detected tissues, heart, liver, spleen, kidney and
brain. S1PR1 protein was expressed in the cytoplasm and also demonstrated quantitative changes in expression in
the various tissues between mice infected with the two strains of AIV.
Conclusions: Our results provided the first look at differences in S1PR1 expression patterns in BALB/c mice infected
by non-pathogenic and highly pathogenic H9N2 influenza viruses. This information will not only be helpful in
designing experiments to better understand the role of S1PR1 in virus-host interactions but also in developing
novel anti-influenza agents to minimize the mortality and morbidity associated with highly virulent strains in avian
and human populations.
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The avian influenza virus (AIV) H9N2 subtype was first
characterized in 1966 as causing mild respiratory diseases
in turkeys [1] and, for the first decade after its isolation,
was found only in shorebirds and mallards [2]. However,
after almost 50-years evolution and propagation, the
H9N2 viruses have spread across most of the earth, cir-
culating in wild bird and domestic poultry populations
worldwide. Although AIV infections commonly result* Correspondence: mliao@scau.edu.cn; ningzhyong@scau.edu.cn
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reproduction in any medium, provided the orin low mortality in avian populations, in immunosup-
pressed chickens, recent isolates of H9N2 virus have
been associated with high mortality in young chicks and
a severe decline in egg production in laying chickens via
secondary bacterial infections of the upper respiratory
tract, resulted in significant economic losses of domestic
poultry in many Asian countries [3-9]. In addition to the
enormous financial losses, avian influenza virus (AIV)
infections in bird populations with represent a reposi-
tory of virulent genes or conservative gene fragments
that can recombine to form new influenza A strains that
can cross species boundaries, which increasingly aretd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Agarose gel electrophoresis of RT-PCR products of
the S1PR1 of BALB/c mice. M: Marker of DL2000; 1:S1PR1 gene
(1483 bp).
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type of increasing concern, H9N2, has spread across
many countries with a broad range of host species, in-
cluding humans, pigs and poultry [8-10]. For a long-
time, H9N2 influenza virus was ignored because of its
relatively low pathogenicity compared with H5N1.
However, a recent zoonotic outbreak of H7N9 in China
had resulted in many deaths, and the six internal genes
(PA,NS,PB2,PB1,NP,M) of the new H7N9 strain come
from H9N2 [11,12]. Similar involvement also an-
nounced before that some H9N2 and H1N1 hybrid can
replicate in a high titer in vitro and exhibit higher
pathogenicity than both parental viruses [12,13].
Sphingosine-1-phosphate receptor 1 (S1PR1) is one of
the five sphingosine-1-phosphate (S1P) G protein-coupled
receptors (GPCRs). The S1PR1 signaling system exerts its
influence on a wide range of physiologic processes via acti-
vation of several signaling pathways: JAK/STAT, mTOR/
PI3K/Akt, Ras/ERK/MAPK, Phospholipase C activation of
PKC/Ca2+ and cyclic AMP [14,15]. Much research has
been done on the role of on S1PR1 in cancer and neuro-
science. S1PR1-STAT3 upregulation in tumor cells is crit-
ical for maintenance of persistent STAT3 signaling in
cancer cells [16] and can result in premetastatic niche for-
mation through activation of S1PR1-STAT3 and induced
factors, enabling myeloid to invade and proliferate and
apoptosis resistance at premetastic sites [17]. Protein S
protects the blood–brain barrier integrity via Tyro3 and
S1PR1, illuminating potentially novel treatments for
neurovascular dysfunction resulting from blood–brain
barrier damage [18]. However, until recently, little atten-
tion was given to the role of S1PR1 in immune response.
In 2011, Teijaro, et al. used a S1P1 receptor subtype-
selective agonist to suppress innate immune responses,
resulting in suppression of cytokine and chemokine secre-
tion and in significantly reduced mortality during infection
of mice with a human pathogenic influenza H1N1 [19-21].
This indicated a crucial role of S1PR1 in influenza infec-
tion and suggested that S1PR1 signaling may be important
in the immune response to other viral infections as well.
The aim of the current study was to investigate the contri-
bution of S1PR1 to infection with influenza virus by exam-
ining changes in the expression pattern of S1PR1, at the
protein level and mRNA level, in normal (uninfected)
mice compared to those infected with highly pathogenic
and non-pathogenic H9N2 influenza. The results will
contribute to get the function of S1PR1 in the infection
of influenza virus and get the basic data for the strat-
egies of anti-influenza.
Results
Amplification of S1PR1and sequence analysis
The coding nucleotide sequence of S1PR1 gene of BALB/c
was amplified by RT-PCR (Figure 1) and was analyzed by
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puter Center biology workbench: http://workbench.
sdsc.edu/). It was revealed that the S1PR1 amplicon was
approximately 1483 bp, which contained the complete
coding sequence (1149 bp) of the S1PR1 gene, which was
deposited in GenBank (accession no.: JX843822). The de-
duced protein sequence contains 382 amino acid residues,
with a molecular mass of approximately 42 kDa. The
nucleotide sequence of our cloned S1PR1 were aligned
using the software MegAlign (DNAstar, Madison, WI) and
were compared with similar sequences retrieved from
the GenBank database (http://www.ncbi.nlm.nih.gov/,
NCBI, US National Library of Medicine). Our cloned
S1PR1 from BALB/c mice was 99%, 89%, 88%, 88%
87% and 86% identical with S1PR1 sequences previ-
ously cloned and submitted to GenBank for C57BL/6 J
mice (RefSeq# NC_000069.6), horse (NC_009148.2),Figure 2 Relative mRNA expression level of S1PR1 in the detected tis
S1PR1 mRNA in control group; B, Differences in expression levels of S1PR1
*, P < 0.05; **, P < 0.01. Data are represented as mean ± standard deviation (human (NM_001400.4), cattle (NM_001013585.4), sheep
(NC_019458.1) and dog (NC_006588.3), respectively.
mRNA expression of S1PR1 gene in BALB/c mice detected
by Real-Time PCR
The specificity of the S1PR1 gene and β-actin fragments
obtained by PCR were confirmed by nucleotide se-
quences and by melting-curve profile analysis. In the
normal BALB/c mice, S1PR1 mRNA was ubiquitously
expressed in all the tissues examined, and the expres-
sion levels of S1PR1 was significantly lower in heart,
spleen, lung and kidney tissues compared with liver
(Figures 2A and B). There was no significant difference
between S1PR1 expression levels in the liver and brain
(Figure 2A). BALB/c mice challenged with the Ts strain
demonstrated no observable symptoms of influenza infec-
tion in our previous reports [22,23]. However, when wesues of control, TS and V groups. A, Relative expression levels of
mRNA between challenged group (TS- or V-) and the control group.
SD). All samples were tested in triplicate.
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between corresponding organs in negative control (un-
challenged) BALB/c mice and BALB/c mice challenged
with the TS strain, S1PR1 expression was significantly
lower (P < 0.01) in heart, liver, kidney tissues (Figure 2B).
However, levels of S1PR1 mRNA were significantly higher
(P < 0.01) in the brain of TS-challenged mice compared to
negative controls (3.10 ± 0.014 vs 0.47 ± 0.060) (Figure 2B).
In comparison with BALB/c mice challenged with a highly
virulent influenza strain (V), BALB/c mice challenged with
the Ts showed significantly lower levels of S1PR1 mRNA
in heart (P < 0.01), spleen (P < 0.01), kidney (P < 0.01), and
liver (P < 0.05) (Figure 2B). However, mice in the TS-
challenged group had significantly higher levels (P < 0.01)
of S1PR1 mRNA in the brain than V-challenged mice
(3.10 ± 0.014 vs 1.96 ± 0.049) (Figure 2B). The mRNA
expression levels of S1PR1 in the heart, spleen, kidney and
brain were significantly higher (P < 0.01) in V-challenged
mice compared to negative controls (Figure 2B). No
significant differences were seen in the S1PR1 mRNA
levels of the lung among the three groups, and no
significant differences were seen between mRNA levels
in spleen of TS-challenged mice and negative controls
(Figure 2B).
S1PR1 expression detected by immunohistochemistry
Immunohistochemical detection was performed to show
the distribution of S1PR1 protein in the tissues of all
three group mice (Figure 3). In the lung (Figures 3A, B
and C), the epithelial cells the bronchi and bronchioles
and the alveolar cells of the pulmonary alveoli were
positive in the lung, and there is no significant differ-
ence between the three groups. In the liver (Figures 3D,
E and F), hepatocytes were strongly positive in the cyto-
plasm but not in nucleus, and the endothelial cells of
the hepatic blood vessels and sinus were negative. Over-
all staining of liver for S1PR1 protein in TS-challenged
mice is lower than in V-challenged mice or the negative
control group. In the brain (Figures. 3G, H and I), the
S1PR1 showed positive staining in the cytoplasm of
neurocytes and locally in the cells, and the amount of
staining for the TS group is lower than for the control
and V group. In the spleen (Figures 3J, K and L), only
some splenocytes endothelial cells were positive, and
this number is lower in the V group than in the control
and TS group. In the kidney (Figures 3M, N and O), the
endothelial cells of the some renal tubular and wall cell
of glomeruli of kidney are stained diffusely for S1PR1
whereas the endothelial cells of the glomerulus were
negative in normal control and TS group. There is no
detection of S1PR1 expression in the kidney in V group
(Figure 3O). Myocardial cells (Figures 3P, Q and R) were
strongly positive in the normal control but it showed
locally positive in the TS and V groups.Discussion
H9N2 subtype AIV has been circulating in domestic
poultry worldwide after almost 50-years evolution and
propagation. Though it is defined as a low pathogenic
avian influenza itself, H9N2 has caused enormous losses
of domestic poultry due to secondary infections, particularly
in Asia and countries of the Middle East, H9N2 subtype
AIV also represents a significant threat for novel zoonotic
influenza viruses in humans via supplying virulent genes or
conservative fragments to other influenza strains. Six of
eight gene fragments of H7N9 influenza strains isolated in
a recent outbreak of AIV in China were verified as being
from H9N2 [12]. Moreover, recent reports have shown that
the domestic cats and dogs were also susceptible to H9N2
AIV infection [24,25]; these species might pose an even
bigger risk as a reservoir of zoonotic influenza virus due to
their close proximity to humans in both developed and
developing nations. Additionally, dogs may be able to
transmit AIV strains between avian populations [25].
Inflammation is one of the common pathological fea-
tures of viral infections, particularly in influenza infection,
which is often characterized by excessive inflammation
factors and cytokines, resulting in pathological damage of
tissues and even fatalities in severe infections. Modulating
inflammation during ongoing antiviral therapy to reduce
resultant immunopathology is very likely to be beneficial
and increase the chances to lower morbidity and mortality
associated with some AIV strains [26]. Since the S1PR1
was first discovered on endothelial cells, it has been found
engaging in a wide range of pathophysiological activities
via modulating S1P signaling. S1PR1, by binding with S1P,
could induce endothelial cell migration, proliferation, sur-
vival, and morphogenesis [27,28]. A precise S1P and
S1PR1 signaling balance was found to be responsible for
the cell growth and regulation of cell metabolism in mam-
mals [29,30]. In addition, S1PR1 has been shown to con-
trol lymphocyte exit and to be required for the egress of
both B and T cells [31,32]. However, an imbalance of S1P-
S1PR1 system also participates in pathologic conditions
such as cancer and inflammatory diseases [33,34].
It is because of S1PR1’s pivotal role in modulating the
cellular inflammatory response that many researchers
shifted their focuses to its role in inflammatory signal-
ing in recent years. It has been demonstrated that over
expression of S1PR1 along with other 4 S1P receptors
will maintain a basal value even 7 days after injury,
suggesting that S1PR1 activation may be a short-term
injury response [35]. A recent investigation uncovered a
novel function of S1PR1 as the critical regulator of effi-
cient thrombopoiesis; mice lacking the S1P receptor
S1PR1 developed severe thrombocytopenia, which sug-
gests new therapeutic approaches for patients with this
disease [36]. The role of S1PR1 in influenza infection has
also been preliminarily studied by John R. Teijaro, et al.
Figure 3 Distribution of S1PR1 in the tissues of BALB/c mice. Tissues were sectioned and immunohistochemical analysis was performed.
Scale bar = 50 μm. A, B and C: lung of control, Ts and V group, respectively; D,E and F: Liver of control, Ts and V group, respectively; G,H and I:
brain of control, Ts and V group, respectively; J,K and L: spleen of control, Ts and V group, respectively; M,N and O: kidney of control, Ts and V
group, respectively; P, Q and R: heart of control, Ts and V group, respectively.
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S1P1 signaling, resulting in reduced mortality during in-
fection of mice with a human pathogenic strain of influ-
enza virus [20,21]. Hence, we hypothesized that S1PR1
might occupy a key position in influenza inflammation,
protecting the host from excessive inflammatory symp-
toms caused by H9N2 infection, which we demonstratedin our previous reports [22,23]. Based upon our previous
findings, we hypothesized that S1PR1 expression might be
altered in mice challenged with two AIV strains associated
with strong and weak inflammatory and related to differ-
ences in their respective mortality rates [21].
We examined the gene expression profile of S1PR1 to
elucidate its function in influenza infection in mice
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and low (TS) pathogenicity. We found that S1PR1 mRNA
was expressed in all tissues of BALB/c mouse examined;
this may be the site-specific role of different tissues in
infection. When using different influenza virus strains
infected the BALB/c mice, the S1PR1 gene expression
level showed different variation trends, we speculated this
may be related to the strains of influenza virus and need
to be further research. There were discrepancies, however,
between the mRNA and protein expression levels in some
tissues. Inconsistencies between mRNA and protein levels
can be caused by many factors: post-transcriptional con-
trol, lags in protein translation, deactivation of post-
translational protein processing, shorter half-lives of
mRNA than proteins in vivo, and regulation of excessive
mRNA by host molecules such as miRNA. We found
significant differences in the expression pattern of
S1PR1 mRNA or protein, both between uninfected and
influenza-infected BALB/c mice and between those
infected with H9N2 influenza strains that are non-
pathogenic and highly pathogenic in mice (TS and V
strains, respectively). These differences were most evident
in tissues of heart, liver, kidney, brain. This difference cor-
relates well with our previous reports, which identified dif-
ferences in pathology in these organs between BALB/c
mice infected with TS and V stains infection. Inflamma-
tion was more apparent in BALB/c mice infected with A/
chicken/Guangdong/V/2008 (VK627), and this was con-
firmed by detection of increased expression of inflamma-
tory cytokines [23]. Although our results confirm previous
reports of the role of S1PR1 in pathology associated with
infection with influenza, elucidation of the specific mech-
anism of S1PR1 in the inflammatory response to AIV
infections requires further study.
Conclusion
In conclusion, our data showing the distribution tissue
expression pattern of S1PR1 in AIV-infected mice fur-
ther supports a crucial role for S1PR1 in the physio-
logical and pathological processes in influenza. The
tissue-specific alteration in the expression pattern of
S1PR1 in mice infected with highly pathogenic AIV
compared with mice challenged with non-pathogenic
AIV suggests differences in immune response are very
likely to be associated with S1PR1 signaling pathways.
Further research on S1PR1 signaling may enhance re-
search and development of anti-influenza drugs and pro-
vide new opportunities for prevention and treatment of
other human viral diseases.
Materials and methods
Viruses and BALB/c mice infection by H9N2 influenza virus
The viruses used in study were H9N2 AIV A/chicken/
Guangdong/TS/2004 (TSE627), or TS, and A/chicken/Guangdong/V/2008 (VK627), or V. We previously deter-
mined that V virus replicates efficiently in mouse brains
and is highly pathogenic in mice while TS-infected mice
exhibit no clinical symptoms, and TS virus is not detect-
able in the brains of TS-infected mice [22,23]. Influenza
viral titer was determined by plaque assay, as described
in our previous study [22]. A total of 24 six-week old
female mice (Guangdong Experimental Animal Center,
Guangzhou, China) were randomly divided into 3 groups:
TS group (infected by intranasal inoculation with 104 PFU
of TS influenza virus in 50 μl of sterile, endotoxin-free
PBS); V group (infected intranasally with 104 PFU of V
influenza virus in 50 μl of sterile, endotoxin-free PBS); and
Control group (treated intranasally with 50 μl of PBS
alone). Mice were surveilled for daily weight loss, as a
measure of morbidity, as our previous reports [22,23]. All
animal experiments were conducted in a facility accredited
by the Association for Assessment and Accreditation of
Laboratory Animal Care International and in accordance
with the guidance of CDC’s Institutional Animal Care and
Use Committee. Additionally, all animal experiments had
been authorized by Guangdong Province Animal Disease
Control Center.
Tissue preparation
All mice were anesthetized and euthanized at day 5 after
inoculation. Tissues including heart, liver, spleen, lung,
kidney, brain and stomach were harvested promptly.
Each tissue was divided into two parts: one part was
frozen in liquid nitrogen for 2 h then stored in −86°C
until needed for RNA extraction; the other part was
fixed in 10% neutralized buffered formalin for more than
one week for immunohistochemistry.
RNA extraction
Total RNA was extracted from 100 mg of frozen tissue
from each organ using Trizol Reagent (Takara Biotech,
Dalian, China), in accordance with the manufacturer’s
instructions. After being mixed with trichloromethane
and centrifuged, the supernatant was transferred and
mixed with isopropanol and ethanol. Precipitated RNA
was dissolved in RNAse-free H2O then treated with
RNase-free DNase I to remove possible contaminating
DNA before storage at −86°C.
S1PR1 gene cloning
cDNA was generated from total RNA using reverse-
transcriptase (Takara Biotech, Dalian, China), according to
the manufacturer’s guidelines. Primers were synthesized as
follows: 5’-TGCCTGGAGAAATACC-3’ (forward), 5’-TT
CCCAGTGCATTGTT-3’ (reverse). The S1PR1 gene was
amplified by polymerase chain reaction (PCR) in a 50 μl
reaction volume with the following programmed condi-
tions: Denaturation at 95°C for 5 min; 35 cycles
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and elongation at 72°C for 1 min); followed by a final
elongation cycle at 72°C for 10 min. The cDNA produced
by PCR were resolved by 1.5% agarose gel electrophoresis
and visualized by ethidium bromide (EB) staining. Bands
were purified by Gel Extraction Kit (Takara Biotech,
Dalian, China). An aliquot of each purified PCR products
were then cloned into pMD18-T vector (Takara Biotech,
Dalian, China), and positive clones were sequenced by
Takara Biotech company and were blast in pubmed.Real time quantitative PCR
The remaining purified cDNAs generated from selected
tissues by PCR were normalized to the expression levels of
the endogenous β-actin housekeeping gene Quantitative
real-time PCR was performed in a total 25 μl reaction
volume containing 2 μl of total cDNA, 0.5 μl of forward
and reverse primers (20 μM each), 22 μl SYBR® Premix Ex
Taq™ reaction mixture (Takara Biotech, Dalian, China)
using Bio-Rad iQ™5 Real-Time PCR Detection System
(Applied Biosystems, Carlsbad, CA). The primers for
S1PR1 gene fragment and β-actin are as follows: S1PR1:
5′-TGCCTGGAGAAATACC-3′ (forward), 5′-TTCCC A
GTGCATTGTT-3′ (reverse), β-actin: 5′-CATCCGTAAA
GACCTCTATGCCAAC-3′ (forward), 5′-ATGGAGCCA
CCGATCCACA-3′ (reverse). The reaction was carried
out with the following programmed parameters: 35 cycles
(95°C for 30 s, 55°C for 40 s, and 72°C for 30 s); followed
by a final elongation cycle at 72°C for 10 min. All reactions
were performed in triplicates. The relative expression level
of S1PR1 gene was calculated by normalizing the levels of
S1PR1 transcripts to that of β-actin transcripts using a
relative standard curve method. The expression diversity
of the S1PR1 gene was transformed using the 2−ΔΔCt for-
mula and normalized with β-actin expression. The melting
curves for each PCR were carefully analyzed to avoid
nonspecific amplifications in PCR products. Data was ana-
lyzed using GraphPad Prism 5 (GraphPad Software, La
Jolla, CA). Independent sample (two-tailed) t-test and one
way anove was used to determine statistical significance
between samples. A p-value less than 0.05 (P < 0.05) was
considered to be statistically significant, while a p-value
less than 0.01 (P < 0.01) was considered to be highly
significant.Immunohistochemical detection
Samples of formalin fixed tissues were trimmed,
dehydrated, embedded in melted paraffin, sliced into
4 μm thick sections and finally mounted on silanized
slides pre-treated with silicon. Endogenous peroxidase
activities in tissue sections were inactivated in 3% H2O2
for 10 min at room temperature and washed 3 times by
0.02 M PBS (pH = 7.2) at 5 min intervals. Heat-inducedepitope retrieval was performed by immersing tissue
sections in 10 mM sodium citrate pH 6.0 at high pres-
sure, 100°C for 10 min and then cooled naturally. After
being washed 3 times in PBS for 5 min, sections were
incubated with rabbit anti-S1PR1 polyclonal antibody
(PROTEINTECH, USA), diluted 1:100, for 1.5 h at 37°C.
Sections were again washed 3 times in PBS then incubated
with HRP-conjugated goat anti-rabbit IgG antibody for
1 h at 37°C. S1PR1 was then visualized by DAB (3, 3’-
diaminobenzidine-tetrahydrochloride) for 4 min according
to the manufacturer’s guidelines (ZSGQ-BIO, China).
Tissues were dyed using hematoxylin for 1 min, washed
under running water for 10 min, dehydrated with histo-
logic grade ethanol, vitrified by dimethylbenzene, and,
finally, embedded in neutral balsam.
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